ADMA Biologics, Inc.
ADMA
$17.10
-$0.20-1.16%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 2.31% | 58.03% | 100.86% | 16.92% | 41.16% |
Total Receivables | 264.38% | 100.34% | 82.34% | 60.10% | -18.02% |
Inventory | 6.48% | -3.12% | -1.54% | 5.32% | 11.14% |
Prepaid Expenses | 46.42% | 129.59% | 50.52% | 86.88% | 5.85% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 31.57% | 27.28% | 28.95% | 16.26% | 14.07% |
|
|||||
Total Current Assets | 31.57% | 27.28% | 28.95% | 16.26% | 14.07% |
Net Property, Plant & Equipment | 4.70% | 1.57% | -0.20% | -3.06% | -4.27% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.01% | 0.01% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.01% | 0.01% |
Total Other Intangibles | 10.02% | 40.81% | -7.82% | 1.70% | -26.95% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1,591.21% | 1,411.51% | 1,825.85% | -13.44% | -16.98% |
Total Assets | 48.35% | 45.51% | 48.45% | 11.93% | 9.73% |
|
|||||
Total Accounts Payable | 109.95% | 19.91% | 29.11% | 47.63% | 17.33% |
Total Accrued Expenses | 4.92% | -26.82% | -6.30% | -11.12% | -14.87% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -1.31% | 8.69% | 16.56% | 21.38% | 16.59% |
Total Finance Division Other Current Liabilities | 225.03% | 151.21% | 115.04% | 25.46% | 167.32% |
Total Other Current Liabilities | 225.03% | 151.21% | 115.04% | 25.46% | 167.32% |
Total Current Liabilities | 69.64% | 0.77% | 11.52% | 7.29% | 5.30% |
|
|||||
Total Current Liabilities | 69.64% | 0.77% | 11.52% | 7.29% | 5.30% |
Long-Term Debt | -44.00% | -44.57% | -44.61% | -28.66% | -6.58% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 1.30% | -12.53% | -12.46% | -11.04% | -10.17% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -34.65% | -24.55% | -15.20% | -2.19% | -2.15% |
Total Liabilities | -14.92% | -30.44% | -28.00% | -19.66% | -4.14% |
|
|||||
Common Stock & APIC | 2.52% | 2.02% | 2.52% | 1.92% | 1.05% |
Retained Earnings | 45.78% | 42.33% | 39.05% | 13.94% | 7.08% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 111.57% | 142.94% | 158.14% | 53.13% | 28.28% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 111.57% | 142.94% | 158.14% | 53.13% | 28.28% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 111.57% | 142.94% | 158.14% | 53.13% | 28.28% |
|